AI-generated summary
The authors reviewed 16 preclinical studies in experimental models to examine photobiomodulation settings for preventing oral mucositis caused by non-surgical cancer treatment. They report that no consensus on optimal parameters has been reached, though 660 nm wavelength, 40 mW power density and 2 to 6 J/cm2 fluence were most commonly used, with reduced severity and no reported severe side effects. The authors conclude the approach is promising but that optimal parameters still need investigation.
- Studies included
- 16
- Who or what was studied
- Experimental (preclinical) models of non-surgical cancer treatment-induced oral mucositis
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The review includes only preclinical experimental studies and the authors state that no consensus on optimal treatment parameters has been reached.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 6 J/cm2
- Power
- 40 mW
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Low-level laser therapy, Wavelength, Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.